Table of contents: VOL. 149, NO. 9 - May 3, 2004
Growing Against The Grain Amgen CEO Kevin Sharer stands accused of remaking the world's biggest biotech company in the image of Big Pharma. But that might be a good thing.
Rx for Investors Rising demand. Soaring costs. New technology. They're all driving a health-care boom. Here's how you can profit from it now.
When Will They Stop? Despite last year's loud cries for pay reform, FORTUNE 500 CEOs made more money than ever in 2003. Here's why change is taking so long.
We found it! The Venture Rebound VCs may worry that too much cash is chasing too few good deals. But for entrepreneurs in a few key sectors, it's springtime for funding.
50 Years Of The Fortune 500
Camera Not So Obscura When it comes to gadgets, men are from Mars, women are down-to-earth. Here are two new cameras sure to make moms smile.
Private Sector Soldiers With violence escalating in Iraq, tens of thousands of U.S. contractors are getting more than they bargained for.
Test-Driving The Destroyatron Imagine a machine that will take any object you put into it--anything at all--and reduce it to a cloud of atoms. Heh-heh.